Aldea Pharmaceuticals announces closure of $24M Series B equity financing Aldea Pharmaceuticals.

‘We likewise have the opportunity to use our scientific strategy in the treatment of patients with Fanconi anemia, a uncommon genetic disease seen as a chromosomal instability, bone marrow failure and an increased threat of cancer. The funds we have secured with this funding should allow us to generate proof-of-concept data in both of these indications.’ Â.. Aldea Pharmaceuticals announces closure of $24M Series B equity financing Aldea Pharmaceuticals, a company pioneering novel therapeutics to take care of aldehyde metabolism disorders, today announced that it has closed a $24 million Series B equity financing.NYC Wellness Commissioner on soda ban: ‘We are just making healthy choices less difficult’ NY City’s sugary drink limits: What’s next? The CDC study is founded on interviews with an increase of than 11,000 U.S. Adults from 2007 through 2010. Participants were asked extensive questions about what they ate and drank over the previous 24 hours. The scholarly study discovered that the U.S. Adult population consumes typically almost 100 calories per day from alcoholic beverages, with men consuming more than ladies. On any given time, about one-third of men and one-fifth of ladies consumed calories from beer, liquor or wine.